Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from IMAGO

Ranking the Kopa Trophy 2024 Nominees

Spain and Barcelona player, Lamine Yamal, is the favorite to win the 2024 Kopa Trophy.

Sports Illustrated

Photo of Rafael Nadal and Roger Federer in tears wins World Sports Photography Award

A captivating emotional photo of tennis player Rafael Nadal and Roger Federer in tears wins the 2023 World Sports Photography Awards

Digital Camera World

New to Investing? Give These 2 Robust Stocks a Try

Despite the recent wild swings in the stock market, experts believe stocks to stabilize next year. However, as uncertainties remain, new investors should consider investing in stocks that offer compelling yields, such as Merck & Co (MRK) and Verizon Communications (VZ). Keep reading….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Croatia, Morocco’s World Cup Feats Can’t Be Overlooked

Qatar’s two underdog stories produced all-time runs, even though they didn’t end up in the final.

Sports Illustrated

4 Pharmaceutical Stocks You Can Always Rely On

The pharmaceutical industry is well-positioned to witness substantial growth, driven by the prevalence of chronic diseases, the aging population, and increased healthcare spending. Given the industry’s promising growth prospects, we think it could be wise to invest in fundamentally sound pharmaceutical stocks Johnson & Johnson (JNJ), Merck & Co (MRK),…

StockNews.com

3 Stocks Insiders Can’t Stop Buying This Month

After signs of cooling inflation, investors are hopeful that the Fed will slow its rate hikes over the coming months. With surging optimism, fundamentally strong stocks Merck (MRK), Coca-Cola (KO), and Verizon (VZ), which have seen increased insider buying, might be ideal investments now. Continue reading.

StockNews.com

Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout

Biotech stock Imago BioSciences broke out and hit a record high Monday after Merck pledged to buy it for $1.35 billion.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

F1 Drivers Call For Changes to Track: Three Takeaways From Miami

Max Verstappen edged past Charles Leclerc, and Mercedes had a topsy turvy weekend. But was the track actually successful?

Sports Illustrated

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.